Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEDIFAST INC Common Stock (NY:MED)

10.82 +0.01 (+0.09%)
Streaming Delayed Price Updated: 10:53 AM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Preview: Medifast's Earnings ↗
 
Via Benzinga
News headline image
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2023
From Medifast
Via Business Wire
News headline image
5 Value Stocks In The Consumer Cyclical Sector ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2023 ↗
 
Via Benzinga
News headline image
Friday Is Your Last Chance To Buy Medifast Before The Dividend Payout ↗
 
Via Benzinga
News headline image
Institutions Are Buying Under Appreciated Consumer Staples Now
Institutions are buying undervalued consumer staples with solid cash flow, dividends, and healthy balance sheets like Medifast. 
Via MarketBeat
News headline image
Wall Street's Most Accurate Analysts Say Hold These 3 Risk Off Stocks Delivering High-Dividend Yields ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
Are These Consumer Staples Too Cheap for Investors To Ignore?
The consumer staples sector is beaten down and offering a significant value and high yield for long-term-minded investors 
Via MarketBeat
Topics Bonds Cannabis Economy
News headline image
Want $500 in Passive Income? 2 High-Dividend Stocks to Snap Up ↗
These consumer-oriented businesses pay market-smashing dividends to shareholders. 
Via The Motley Fool
News headline image
Medifast Stock Analysis - Update ↗
A look at the dramatic changes in Medifast‘s fundamentals and how it has affected the stock. 
Via Talk Markets
News headline image
Medifast's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Medifast's Ex-Dividend Date Is Monday, Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Earnings Preview For Medifast ↗
 
Via Benzinga
News headline image
Electronic Arts, Tractor Supply And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed lower by over 1% on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
A Look Into Consumer Cyclical Sector Value Stocks ↗
 
Via Benzinga
News headline image
Medifast: Transforming Lives And Reshaping The Health & Wellness Industry
Medifast: Transforming Lives And Reshaping The Health & Wellness Industry 
Via News Direct
Medifast: Transforming Lives And Reshaping The Health & Wellness Industry
By Ernest Dela Aglanu, Benzinga 
Via TheNewswire.com
News headline image
Medifast: Transforming Lives And Reshaping The Health & Wellness Industry ↗
The health and wellness industry has seen a surge in recent years, driven by increasing demand for health-focused products and services. Consumer awareness and interest has grown, viewing wellness... 
Via Benzinga
News headline image
Medifast: Dividend Insights ↗
 
Via Benzinga
News headline image
Medifast Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
7 Small-Cap Stocks Signaling a Sizeable Breakout ↗
While the segment is risky, if you want to maximize your return potential, these small-cap breakout stocks should entice. 
Via InvestorPlace
News headline image
Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 5% Dividend Yields ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 6% Dividend Yields ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
7 Safe High-Yield Dividend Stocks to Buy in June 2023 ↗
While it’s extremely difficult to have your cake and eat it too, these top safe high-yield dividend stocks may accomplish just that. 
Via InvestorPlace
News headline image
Check Out 3 High-Yielding Dividend Stocks In Consumer Staples Sector From Wall Street's Most Accurate Analysts ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
Jenny Craig Loses All Its Weight, Confirms Closure After 40 Years: Who Benefits? ↗
Jenny Craig Inc., a once-popular weight loss and nutrition business, announced its closure after 40 years due to an inability to secure additional financing. 
Via Benzinga
News headline image
Check Out 3 High-Yielding Dividend Stocks In Defensive Sector From Wall Street's Most Accurate Analysts ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
11 Stocks: 9 Dividend Payers 2 For Growth ↗
Not all stocks are the same, and not all stocks serve the investor’s needs. 
Via Talk Markets
News headline image
Earnings Scheduled For May 1, 2023 ↗
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
News headline image
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.